Renalytix Plc

5.50pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:RENXHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 8Y CAGR (31.81%)
Div yield —
ROE —
Medical (Healthcare Information Services)
Beta (5Y) 1.55
PE TTM —
TSR TTM (33.33%)
Mkt cap £33.21M
ROIC (2482.14%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
5.91p
7.44%
(74.32%)
Hold 8|6|1|4|6
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.08
0.08
0.08
0.09
(1.63%)
(0.14%)
1.58%
14.46%
Revenue$M
1.676
1.665
1.672
1.643
(0.63%)
(3.21%)
(4.32%)
(4.35%)
Peers (US$43.48M)
Cap (US$)
PE
231.6M
—
49.74M
—
Capital
TTM
5Y
10Y
Leveragex
0.142
(0.294)
(0.217)
EBIT/Intx
0.799
0.058
0.073
Own earn%
(15.70)
(62.41)
(77.44)
Sh yield%
52.67
28.06
28.72
Owners
Insiders/Inst%
11.80
49.93
Short interest%
5.18
SBC / revenue%
0.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
17–25
$1 testx
—
Incr. ROIC%
12